1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
(
- Contribution to journal › Article
- 2018
-
Mark
Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53
(
- Contribution to journal › Article
- 2015
-
Mark
Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours - A prognostic test after surgical resection.
(
- Contribution to journal › Article
-
Mark
Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.
(
- Contribution to journal › Article
- 2014
-
Mark
Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors.
(
- Contribution to journal › Letter
- 2013
-
Mark
Assessment of Fusion Gene Status in Sarcomas Using a Custom Made Fusion Gene Microarray
(
- Contribution to journal › Article
-
Mark
Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
(
- Contribution to journal › Article
- 2011
-
Mark
Fusion Gene Microarray Reveals Cancer Type-Specificity Among Fusion Genes
(
- Contribution to journal › Article
- 2010
-
Mark
Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group.
(
- Contribution to journal › Article
- 2009
-
Mark
Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours
(
- Contribution to journal › Article